Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells (Q40002468)

16 September 2017

Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells (English)

1 reference

16 September 2017

0 references

R Wang

1

1 reference

16 September 2017

F Lin

2

1 reference

16 September 2017

X Wang

3

1 reference

16 September 2017

P Gao

4

1 reference

16 September 2017

K Dong

5

1 reference

16 September 2017

A-M Zou

6

1 reference

16 September 2017

S-Y Cheng

7

1 reference

16 September 2017

S-H Wei

8

1 reference

16 September 2017

H-Z Zhang

9

1 reference

16 September 2017

14 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

15

1 reference

16 September 2017

402-412

1 reference

16 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2008.16

16 September 2017

0 references

cites work

Livin, a novel inhibitor of apoptosis protein family member

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

KIAP, a novel member of the inhibitor of apoptosis protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The therapeutic potential of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Specific interference with gene function by double-stranded RNA in early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The silent treatment: siRNAs as small molecule drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The inhibitors of apoptosis: there is more to life than Bcl2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Livin/ML-IAP as a new target for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

inferred from DOI database lookup

7 January 2021

based on heuristic

Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2008.16

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference